Concourse Financial Group Securities’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3341 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4729 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4718 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4758 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4760 |
|
|
2023
Q4 | – | Sell |
-15
| Closed | -$589 | – | 4700 |
|
|
2023
Q3 | $589 | Hold |
15
| – | – | ﹤0.01% | 2158 |
|
|
2023
Q2 | $702 | Hold |
15
| – | – | ﹤0.01% | 2182 |
|
|
2023
Q1 | $714 | Hold |
15
| – | – | ﹤0.01% | 2209 |
|
|
2022
Q4 | $733 | Sell |
15
-441
| -97% | -$21.6K | ﹤0.01% | 2206 |
|
|
2022
Q3 | $23K | Sell |
456
-42
| -8% | -$2.12K | ﹤0.01% | 1252 |
|
|
2022
Q2 | $24K | Sell |
498
-25
| -5% | -$1.21K | ﹤0.01% | 1386 |
|
|
2022
Q1 | $31K | Sell |
523
-1,999
| -79% | -$118K | ﹤0.01% | 1322 |
|
|
2021
Q4 | $200K | Buy |
2,522
+178
| +8% | +$14.1K | 0.01% | 725 |
|
|
2021
Q3 | $208K | Buy |
2,344
+7
| +0.3% | +$621 | 0.01% | 707 |
|
|
2021
Q2 | $233K | Buy |
2,337
+21
| +0.9% | +$2.09K | 0.01% | 663 |
|
|
2021
Q1 | $208K | Sell |
2,316
-637
| -22% | -$57.2K | 0.01% | 669 |
|
|
2020
Q4 | $279K | Sell |
2,953
-410
| -12% | -$38.7K | 0.02% | 518 |
|
|
2020
Q3 | $242K | Buy |
+3,363
| New | +$242K | 0.02% | 493 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3616 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3619 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3578 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3320 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3610 |
|